Trial Information
Epidemiological Study to Describe NSCLC Clinical Management Patterns in MENA
Epidemiological study to describe NSCLC clinical management patterns in MENA
Inclusion Criteria:
- Confirmed NSCLC diagnosis (e.g. bronchoscope or FNAB), all stages, men and women,
attending the responsible department of treating this type of patients for the first
time between November 1st, 2011 and August 30th, 2012 For PRO
- Sub-sample:
- ability to read and write since they will be asked to participate in the PRO
part of the study.
- Selection will not be based on the disease stage of each patient, in order to avoid a
selection bias.
Exclusion Criteria:
- According to the study design there will not be any exclusion criteria in order to
provide a high validity and to obtain the most accurate real daily practice
information.
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Outcome Measure:
Use of health resources by collecting data about hospital description and characteristics, Disease Diagnosis Procedures and Therapy information
Outcome Time Frame:
April 2014(26 Months)
Safety Issue:
No
Principal Investigator
Kakil Rasul, CONSULTANT
Investigator Role:
Principal Investigator
Investigator Affiliation:
Hamad Medical Corporation, Doha, Qatar
Authority:
United Arab Emirates: Drug Control Department - Medicines and Pharmacy Control - Ministry of Health
Study ID:
NIS-OAE-XXX-2011/1
NCT ID:
NCT01562665
Start Date:
February 2012
Completion Date:
December 2013
Related Keywords:
- Non Small Cells Lung Cancer
- All patients with NSCLC attending participating hospitals
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms